Skip to content

Knowledge Accumulation and Industry Evolution The Case of Pharma-Biotech

Spend $50 to get a free movie!

ISBN-10: 052112400X

ISBN-13: 9780521124003

Edition: 2009

Authors: Mariana Mazzucato, Giovanni Dosi

List price: $57.95
Blue ribbon 30 day, 100% satisfaction guarantee!
Out of stock
what's this?
Rush Rewards U
Members Receive:
Carrot Coin icon
XP icon
You have reached 400 XP and carrot coins. That is the daily max!

Customers also bought

Book details

List price: $57.95
Copyright year: 2009
Publisher: Cambridge University Press
Publication date: 12/17/2009
Binding: Paperback
Pages: 468
Size: 6.00" wide x 8.75" long x 1.25" tall
Weight: 1.540
Language: English

M. Cimoli is Professor of Economics at the University of Venice (Ca' Foscari) since 1992 and Economic Affair Officer at ECLAC (Economic Commission for Latin America and the Caribbean) of UNITED NATIONS since 1999. He obtained a DPhil at the SPRU (University of Sussex) and he has held a number of visiting appointments in different universities and institutions (University of Pisa, University Metropolitan of Mexico (UAM), University of Campinas, etc). Giovanni Dosi is Professor of Economics at the Scuola Superiore Sant'Anna in Pisa and Visiting Professor at the University of Manchester. His major research areas include economics of innovation and technological change, industrial organisation…    

Figures
Tables
Contributors
Introduction: innovation, growth and industry evolution
Innovation and Industry Evolution
Pharmaceutical innovation as a process of creative destruction
The evolution of pharmaceutical innovation
Firm and regional determinants in innovation models: evidence from biotechnology and traditional chemicals
Comments on Part I
Firm Growth and Market Structure
Growth and diversification patterns of the worldwide pharmaceutical industry
Heterogeneity in the firms' growth process: the case of the pharmaceutical industry
Entry, market structure and innovation in a history-friendly model of the evolution of the pharmaceutical industry
Comments on Part II
Policy Implications
Effects of research tool patents and licensing on biomedical innovation
Upstream patents and public health: the case for generic testing of breast cancer
Competition, regulation and intellectual property management in GM foods: preliminary evidence from survey data
Governance, policy and industry strategies: agro-biotechnology and pharmaceuticals
The dynamics of knowledge accumulation, regulation, and appropriability in the pharma-biotech sector: policy issues